| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.19 | 0.03 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |